You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – In a genomics market where new approaches are supposed to bury older ones, fluorescence in situ hybridization is proving to be an exception.
Connective Tissue Gene Tests (CTGT) has added 21 new assays to its menu of molecular diagnostics for inherited disorders affecting connective tissues.
SciGene recently introduced its CytoBrite Slide Incubation System for performing fluorescence in situ hybridization and in situ hybridization protocols on between one and 12 slides using Peltier technology for rapid heating and cooling.
SciGene this week launched CytoZyme Stabilized Pepsin, an advanced liquid formulation of pepsin for pre-treating tissue samples in nucleic acid probe-based cytogenetic assays.
Bioline, a subsidiary of Meridian Bioscience, this week launched its Isolate II range of nucleic acid purification kits.
SciGene this week launched its Hyb-Ice Thermal Profiling System, which it is claims is a "affordable and flexible alternative" to standard thermal cyclers on the market for temperature profiling.
By Justin Petrone
Microarray tool vendor SciGene has developed a new microsample incubation system that it will ship to early adopters this quarter ahead of a full launch later this year.
The manufacturing and supply deal marks BlueGnome's entry into the microarray hardware market.
BlueGnome's increased sales to customers in different geographies prompted a decision to directly offer all laboratory equipment associated with microarray processing.
Affymetrix's GeneChip Rice 44K SNP Genotyping Array, QuantiScientifics' A2 DxA MicroArray System, SciGene's Hybex Incubator Insert
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.